Vimarsana
Biggest News Aggregation in the World

Process Development Lab News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Process Development Lab. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Process Development Lab Today - Breaking & Trending Today

Job recruitment drive in Vizag on 25 August to fill 362 vacancies - Vimarsana News

Job recruitment drive in Vizag on 25 August to fill 362 vacancies

On Friday, a job recruitment drive to fill vacancies in 360 jobs will be conducted at the District Employment Exchange in Vizag,

Parijat Industries receives DSIR Recognition - Vimarsana News

Parijat Industries receives DSIR Recognition

New Delhi [India], March 9 (ANI/Parijat): Parijat Industries formulation development laboratory in Ambala, Haryana received its accreditation as an "in-house R&D unit" from the Department of Scientific and Industrial Research (DSIR) in February 2023. DSIR is a part of the Ministry of Science and Technology, Government of India, and has a mandate to carry out the activities relating to promotion, development, utilisation, and transfer of indigenous technology. Parijat has been steadily growing its formidable R&D infrastructure. The company today has 7 different laboratories de...

A Checklist For Risk Assessment Of Nitrosamine Impurities In Oral Solid Dose Drugs - Vimarsana News

A Checklist For Risk Assessment Of Nitrosamine Impurities In Oral Solid Dose Drugs

A Checklist For Risk Assessment Of Nitrosamine Impurities In Oral Solid Dose Drugs By Amol Galande, Ajay Pazhayattil, and Sanjay Sharma Nitrosamine impurities such as N-nitrosodimethylamine (NDMA) are being identified in high-volume drug products such as valsartan, losartan, irbesartan, and ranitidine at levels well above the acceptable daily intake limits. The credit for identifying the higher NDMA levels goes to an independent pharmacy 1 that tests every batch it dispenses, exposing limitations in drug substance and drug product post-approval change assessment and analysis requirements at p...